13 Dec 2018 Antares Pharma Announces The Appointment of Peter S. Greenleaf To Company's Board of Directors Read More
29 Nov 2018 Antares Pharma Announces The Commercial Availability Of XYOSTED™ (Testosterone Enanthate ) Injection – A New Treatment For Adult Men Diagnosed With Testosterone Deficiency Read More
27 Nov 2018 Antares Pharma Partner TEVA Announces Commercial Availability of Generic EpiPen Read More
